Background Case-control genome-wide association studies (GWAS) have identified loci associated with risk for Alzheimer disease (AD), but they require very large sample sizes and identify variants small effect sizes. GWAS of informative endophenotypes more power to novel provide information about biological mechanisms. By analyzing data from 1,269 individuals, we previously AD that were CSF leve...